To further elucidate the pathological roles of ZNF217, we conducted both loss-of-function and gain-of-function studies with human B-ALL cell lines, patient-derived xenograft (PDX) cells, and murine B-ALL cells. Here, ZNF217 is linked to acute lymphoblastic leukemia.